Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
DOI: 10.1369/jhc.3A6209.2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janes, M. S.
Right arrow Articles by Capaldi, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janes, M. S.
Right arrow Articles by Capaldi, R. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry
Volume 52 (8): 1011-1018, 2004
Copyright ©The Histochemical Society, Inc.

Rapid Analysis of Mitochondrial DNA Depletion by Fluorescence In Situ Hybridization and Immunocytochemistry : Potential Strategies for HIV Therapeutic Monitoring

Michael S. Janes, Bonnie J. Hanson, Dani M. Hill, Gayle M. Buller, Jakyoung Y. Agnew, Steven W. Sherwood, W. Gregory Cox, Kunihiro Yamagata and Roderick A. Capaldi

Molecular Probes, Inc. (MSJ,BJH,DMH,GMB,JYA,SWS,WGC), and Institute of Molecular Biology, University of Oregon, Eugene, Oregon (KY,RAC)

Correspondence to: Michael S. Janes, Molecular Probes, Inc., 29851 Willow Creek Road, Eugene, Oregon 97402. E-mail: mike.janes{at}probes.com

Nucleoside reverse transcriptase inhibitors (NRTIs) have been a mainstay in the treatment of human immunodeficiency virus since the introduction of azidothymidine (AZT) in 1987. However, none of the current therapies can completely eradicate the virus, necessitating long-term use of anti-retroviral drugs to prevent viral re-growth. One of the side effects associated with long-term use of NRTIs is mitochondrial toxicity stemming from inhibition of the mitochondrial DNA (mtDNA) polymerase {gamma}, which leads to mtDNA depletion and consequently to mitochondrial dysfunction. Here we report the use of fluorescence in situ hybridization (FISH) and immunocytochemistry (ICC) to monitor mtDNA depletion in cultured fibroblasts treated with the NRTI 2',3'-dideoxycytidine (ddC). These techniques are amenable to both microscopy and flow cytometry, allowing analysis of populations of cells on a single-cell basis. We show that, as mtDNA depletion progresses, a mosaic population develops, with some cells being depleted of and others retaining mtDNA. These techniques could be useful as potential therapeutic monitors to indicate when NRTI therapy should be interrupted to prevent mitochondrial toxicity and could aid in the development of less toxic NRTIs by providing an assay suitable for pharmacodynamic evaluation of candidate molecules. (J Histochem Cytochem 52:1011–1018, 2004)

Key Words: mitochondria • oxidative phosphorylation • mitochondrial DNA • HIV • AIDS • mitochondrial disease • nucleoside reverse • transcriptase inhibitor • cytochrome c oxidase • immunocytochemistry • FISH


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BrainHome page
G. Ferrari, E. Lamantea, A. Donati, M. Filosto, E. Briem, F. Carrara, R. Parini, A. Simonati, R. Santer, and M. Zeviani
Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-{gamma}A
Brain, April 1, 2005; 128(4): 723 - 731.
[Abstract] [Full Text] [PDF]




Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2004